New hope for tough head & neck cancers after first treatment fails
NCT ID NCT07361133
Summary
This study is testing whether two existing drugs, cyclophosphamide and etoposide, given in low, frequent doses, can help control advanced head and neck cancer that has returned or spread after initial chemotherapy. It will involve 120 adults in Egypt and compare the drug combination to a placebo to see if it slows tumor growth and is safe. The goal is to find a new treatment option for patients who have run out of standard choices.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Cancer Institute
Cairo, Cairo Governorate, 11796, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.